Smega Pharmaceuticals Private Limited
About Smega Pharmaceuticals Private Limited
Data last updated:
Smega Pharmaceuticals Private Limited is a private limited company based in Belapur, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 November 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2011PTC223917. Its GSTIN is 27AAQCS5602P1ZN (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1.35 Lakh. It is led by directors including Gautam Kumar Aniruddha Das and Madhav Gaikwad Tulsiram.
Its last annual general meeting (AGM) was held on 27 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at Office No.607 6th Floor A – Wing Hermes Antrium Plot No.57 Sec – 11, Belapur, Maharashtra, India – 400614.
As per the financials filed for FY 2019, the company reported a revenue of ₹34.32 Lakh, a decline of 41% compared to the previous year. For the same year it recorded a net loss of ₹13.92 Lakh (net margin -40.6%) and EBITDA of -₹13.69 Lakh (EBITDA margin -39.9%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years.
As per MCA filings, the company has open charges of ₹40 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Smega Pharmaceuticals Private Limited's registered office is in Belapur, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressOffice No.607 6th Floor A – Wing Hermes Antrium Plot No.57 Sec – 11, Belapur, Maharashtra, India – 400614
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Smega Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Smega Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Smega Pharmaceuticals Private Limited, buy the company report.
Financials of Smega Pharmaceuticals Private Limited
FY 2019 filings availableSmega Pharmaceuticals Private Limited reported revenue of ₹34.32 Lakh (down 41% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 6% over three years, including a 41% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹34.32 Lakh | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹13.69 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹13.92 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -39.9% | ||||
| Net Profit Margin | -40.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Smega Pharmaceuticals Private Limited, buy the company report.
Board of directors of Smega Pharmaceuticals Private Limited
Smega Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gautam Kumar Aniruddha Das Also directs: Ddmc-India Healthcare LLP, Sabgard Pharmaceuticals Private Limited | Director | 14 Nov 2011 | 14 Years 11 Months | Current |
| Madhav Gaikwad Tulsiram | Director | 10 Jan 2017 | 9 Years 10 Months | Current |
| Nilesh Laxman Gajmal | Director | 27 Dec 2016 | 9 Years 10 Months | Current |
Peer comparison
Smega Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Coochbehar Tradelink Private Limited | ₹34.36 Lakh (FY 2018) | -51.0% | Cooch Behar, West Bengal, India | |||
| Sharda Medicoss Private Limited | ₹34.36 Lakh (FY 2019) | 3268.0% | Navi Mumbai, Maharashtra, India | |||
| Clark Rubbers Limited | ₹34.36 Lakh (FY 2024) | -62.0% | Mumbai, Maharashtra, India | |||
| Telmed Pharmaceutical Private Limited | ₹34.34 Lakh (FY 2025) | -28.0% | Ujjain, Madhya Pradesh, India | |||
| Smega Pharmaceuticals Private Limitedthis company | ₹34.32 Lakh (FY 2019) | -₹13.92 Lakh | -40.6% | -41.0% | Belapur, Maharashtra, India | |
| Smithsante Pharmaceuticals Private Limited | ₹34.25 Lakh (FY 2024) | 34.0% | Chennai, Tamil Nadu, India | |||
| Sunbiosmith Pharmaceuticals Private Limited | ₹34.24 Lakh (FY 2025) | 6.0% | Dehradun, Uttarakhand, India | |||
| Goodness Pharmaceuticals Private Limited | ₹34.21 Lakh (FY 2022) | 6.0% | Aligarh, Uttar Pradesh, India |
To see the full peer comparison of Smega Pharmaceuticals Private Limited, buy the company report.
Auditor
Smega Pharmaceuticals Private Limited is audited by ASHWIN KAPSE & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ASHWIN KAPSE & CO | FY 2019 | 129005W |
Shareholding
The shareholding of Smega Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Smega Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Jan 2015 | 10549124 | State Bank of Hyderabad | ₹40 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Smega Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Smega Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Smega Pharmaceuticals has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAQCS5602P1ZN | Maharashtra | Active | 01 Jul 2017 |
| 05AAQCS5602P1ZT | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Smega Pharmaceuticals Private Limited, buy the company report.
Recent activity
Smega Pharmaceuticals Private Limited has 5 board changes on record since 2011: 3 appointments and 2 cessations. The latest: Gautam Kumar Aniruddha Das ceased to be Director on 30 Sep 2021.
Frequently asked questions
Smega Pharmaceuticals is an active private limited company based in Belapur, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 November 2011 (15+ years old) and is registered under CIN U51909MH2011PTC223917.
Smega Pharmaceuticals has 3 current directors:
- Gautam Kumar Aniruddha Das - Director
- Madhav Gaikwad Tulsiram - Director
- Nilesh Laxman Gajmal - Director
The latest financial statements of Smega Pharmaceuticals on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 27 September 2019. Year-wise statements from 2015 are in the company report.
The GSTIN of Smega Pharmaceuticals is 27AAQCS5602P1ZN, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 05AAQCS5602P1ZT (Uttarakhand).
The CIN (Corporate Identification Number) of Smega Pharmaceuticals is U51909MH2011PTC223917. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Smega Pharmaceuticals was incorporated on 14 November 2011, making it 15+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Smega Pharmaceuticals by revenue are Coochbehar Tradelink Private Limited, Sharda Medicoss Private Limited, Clark Rubbers Limited, Telmed Pharmaceutical Private Limited, Smithsante Pharmaceuticals Private Limited and 2 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Gautam Kumar Aniruddha Das ceased to be Director on 30 Sep 2021. Madhav Gaikwad Tulsiram was appointed as Director on 10 Jan 2017. Sumedh Gaikwad Madhav ceased to be Director on 10 Jan 2017. Smega Pharmaceuticals has 5 board changes on record in total.
The registered office of Smega Pharmaceuticals is at Office No.607 6th Floor A – Wing Hermes Antrium Plot No.57 Sec – 11, Belapur, Maharashtra, India – 400614.
Smega Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Smega Pharmaceuticals has open charges of ₹40 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
